Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors

Published:2022-03 Issue:1 Volume:3 Page:e151
ISSN:2691-3593
Container-title:Annals of Surgery Open
language:en
Short-container-title:

Author:

Kjaer Josefine,Clancy Thomas E.,Thornell Anders,Andersson Niklas,Hellman Per,Crona Joakim,Welin Staffan,Sulciner Megan,Powell Brittany,Brais Lauren,Astone Kristina,Baddoo William,Doherty Gerhard,Chan Jennifer A.,Norlén Olov,Stålberg Peter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science

Reference28 articles.

1. Management of functional neuroendocrine tumors of the pancreas.;Öberg;Gland Surg,2018

2. Liver transplantation for unresectable pancreatic neuroendocrine tumors with liver metastases in an era of transplant oncology.;Shimata;Gland Surg,2018

3. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.;Feng;World J Surg Oncol,2019

4. Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas.;Bettini;Dig Liver Dis,2009

5. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.;Zheng;Cancer Med,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastroenteropankreatische neuroendokrine Neoplasien – Chirurgie im multimodalen Konzept;Die Chirurgie;2024-06-27

2. Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy;Annals of Surgical Oncology;2024-05-08

3. Surgery for advanced pancreatic neuroendocrine neoplasms: recommendations based on a consensus meeting of the European Society of Endocrine Surgeons (ESES);British Journal of Surgery;2024-01-31

4. NOMOGRAM CONSTRUCTING AND VERIFYING OF PANCREATIC BODY AND TAIL NEUROENDOCRINE CARCINOMA PATIENTS;3C EMPRESA;2024

5. Surgical treatment of stage IV gastroenteropancreatic neuroendocrine carcinoma: Experience and outcomes in the United States;Journal of Surgical Oncology;2023-07-12